U.S. Banks Stock News

NYSE:USPH
NYSE:USPHHealthcare

Undervalued Small Caps With Insider Action Across Regions

As February begins, U.S. stock markets have shown strong upward momentum with major indices like the Dow Jones and S&P 500 posting significant gains, reflecting investor optimism despite ongoing economic uncertainties such as government shutdowns and trade negotiations. Amidst this backdrop, small-cap stocks in the S&P 600 may present intriguing opportunities for investors seeking value, especially when insider activity suggests potential confidence in these companies' prospects.
NasdaqGS:ALLT
NasdaqGS:ALLTSoftware

High Growth Tech Stocks in US for February 2026

As February 2026 begins, the U.S. stock market is experiencing a strong start with major indices like the Dow Jones Industrial Average and S&P 500 showing significant gains, driven by positive economic indicators such as improved factory activity and new trade deals. In this dynamic environment, high growth tech stocks stand out for their potential to capitalize on technological advancements and evolving market demands, making them an intriguing focus for investors seeking opportunities in a...
NYSE:CDE
NYSE:CDEMetals and Mining

Apollo Global Management And 2 Other Stocks Estimated To Be Trading Below Intrinsic Value

As the U.S. stock market kicks off February with major indices like the Dow Jones and S&P 500 posting significant gains, investors are closely watching for opportunities amid fluctuating economic indicators and geopolitical developments. In this environment, identifying stocks trading below their intrinsic value can provide a strategic advantage, offering potential upside as markets continue to navigate complex global dynamics.
NasdaqGM:APPF
NasdaqGM:APPFSoftware

3 Growth Companies With High Insider Ownership And Up To 15% Revenue Growth

As February begins with a strong rally in the U.S. stock markets, highlighted by significant gains in major indices like the Dow Jones Industrial Average and S&P 500, investors are keenly observing growth companies that have shown resilience amidst fluctuating economic conditions. In this context, companies with high insider ownership and robust revenue growth potential stand out as compelling options for those looking to navigate the current market landscape effectively.
NYSE:PERF
NYSE:PERFSoftware

Outdoor Holding And 2 Other Promising Penny Stocks

As the U.S. stock market kicks off February with a strong performance, highlighted by significant gains in major indices like the Dow Jones and S&P 500, investors are keenly observing opportunities across various sectors. Penny stocks, despite their somewhat outdated moniker, continue to attract interest for their potential to offer value in smaller or newer companies. When these stocks are supported by solid financials, they can present unique growth opportunities for investors seeking...
NYSE:RHLD
NYSE:RHLDProfessional Services

3 Undiscovered Gems In The US Market To Consider For Your Portfolio

As February begins, the U.S. stock market has shown a strong start with major indices like the Dow Jones Industrial Average and S&P 500 posting significant gains, reflecting positive investor sentiment amid economic developments such as a new trade deal with India and expanding manufacturing activity. In this dynamic environment, identifying lesser-known stocks that demonstrate resilience and growth potential can be key to diversifying your portfolio effectively.
NasdaqGM:GCMG
NasdaqGM:GCMGCapital Markets

Top 3 Dividend Stocks To Enhance Your Portfolio

As February begins, U.S. stock markets have shown a robust performance with major indices like the Dow Jones and S&P 500 posting significant gains, reflecting a positive investor sentiment despite ongoing global economic uncertainties. In such an environment, dividend stocks can be an attractive option for investors seeking steady income and potential growth, as they combine regular payouts with the possibility of capital appreciation amidst fluctuating market conditions.
NYSE:STE
NYSE:STEMedical Equipment

STERIS Restructuring And Deals Test Earnings Strength And Dividend Resolve

STERIS plc (NYSE:STE) is pursuing restructuring efforts and targeted acquisitions as it adapts to challenges in the medical technology and sterilization services sectors. These moves are intended to reshape operations and refine the company’s business mix in response to regulatory shifts and inflationary pressures. The changes highlight an effort to support operational flexibility and reinforce STERIS’s position across healthcare and sterilization services. For investors tracking NYSE:STE,...
NYSE:MTB
NYSE:MTBBanks

Is M&T Bank’s Massachusetts Leadership Shift and Conference Push Reframing Its Investor Story (MTB)?

M&T Bank Corporation recently announced the appointment of Jeff Carpenter as Regional President of Massachusetts and, earlier this month, participated in the KBW 2026 Winter Financial Services Conference, with another investor presentation scheduled at the RBC Financial Institutions Conference in New York on March 10, 2026. By elevating an experienced Boston-focused banker and increasing its visibility at high-profile industry conferences, M&T is highlighting both its regional ambitions and...
NasdaqGS:VNET
NasdaqGS:VNETIT

Jefferies Sees VNET Power Expansion And Hyperscale Deal Supporting AI Growth

VNET Group has acquired new power capacity in Ulanqab to support additional data center build out for AI workloads. The company is expected to secure a major hyperscale data center contract in China tied to this expanded capacity. These developments highlight VNET Group's role in supporting rising artificial intelligence infrastructure demand in China. VNET Group (NasdaqGS:VNET), trading at $12.07, is positioned at the center of growing data center and AI infrastructure needs in China. The...
NasdaqGM:KYMR
NasdaqGM:KYMRBiotechs

KT-621 Phase 2b Expansion Across Type 2 Diseases Could Be A Game Changer For Kymera Therapeutics (KYMR)

Kymera Therapeutics recently initiated dosing in its BREADTH Phase 2b trial of KT-621 for moderate to severe eosinophilic asthma and continues its BROADEN2 Phase 2b study in atopic dermatitis, advancing its oral STAT6 degrader program across Type 2 inflammatory diseases. This progress in parallel Phase 2b trials positions KT-621 as a potential platform therapy across multiple high-burden Type 2 conditions, which could influence how investors assess Kymera’s pipeline breadth and clinical...
NYSE:AMTM
NYSE:AMTMProfessional Services

Amentum Holdings (AMTM) Profitability Turn Reinforces Bullish Narratives Despite High P E Ratio

Amentum Holdings (AMTM) opened Q1 2026 with revenue of about US$3.2b and net income of US$44m, translating to basic EPS of US$0.18, as the market weighs these numbers against a share price around US$32.06. Over recent quarters, the company has seen revenue move from US$3.4b in Q1 2025 to US$3.9b in Q4 2025 and then to US$3.2b in Q1 2026, while basic EPS shifted from US$0.05 to US$0.16 over the same 2025 span before landing at US$0.18 this quarter. This sets up a story where profitability...
NasdaqGS:ZBRA
NasdaqGS:ZBRAElectronic

Is Zebra Technologies (ZBRA) Offering Opportunity After Recent Share Price Volatility?

If you are wondering whether Zebra Technologies at around US$256.57 is a bargain or a value trap, you are not alone, as the share price and the fundamentals are sending some very mixed signals. Over the past week the stock is up 10%, yet the 30 day return is a 1.1% decline and the longer term record shows returns of 3.3% year to date, a 27.6% decline over 1 year and a 47.2% decline over 5 years. Recent coverage has focused on how investors are reassessing hardware focused tech names like...
NasdaqGS:CPRT
NasdaqGS:CPRTCommercial Services

Copart Credit Facility Expands Flexibility For Growth And Shareholder Returns

Copart has secured a new $1.25b unsecured senior revolving credit facility. The facility is intended to support acquisitions, capital spending, share repurchases, and international expansion. This new credit line provides additional financial flexibility alongside Copart’s existing resources. For investors watching Copart (NasdaqGS:CPRT), the new facility arrives with the stock trading at $40.35. Over the past week, the share price return is 3.6%, with a 6.8% return year to date and a 16.5%...
NYSE:ACRE
NYSE:ACREMortgage REITs

Ares Commercial Real Estate Q4 Revenue Slump Reinforces Bearish Credit Risk Narratives

Ares Commercial Real Estate FY 2025 Earnings Snapshot Ares Commercial Real Estate (ACRE) has wrapped up FY 2025 with a mixed top line, reporting Q4 total revenue of US$3.4 million alongside basic EPS of a US$0.07 loss per share. The trailing twelve months show total revenue of US$72.7 million and basic EPS of roughly flat at a US$0.02 loss. Across recent quarters, the company has seen revenue move from US$18.5 million in Q4 2024 to US$20.3 million in Q1 2025, US$32.7 million in Q2 2025,...